Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy (Q40667276)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 1996

edit

Language	Label	Description	Also known as
English	Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy	scientific article published on June 1996

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

title

Phase II trial of docetaxel (Taxotere) in patients with metastatic melanoma previously untreated with cytotoxic chemotherapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

main subject

phase II clinical trial

0 references

metastatic melanoma

1 reference

based on heuristic

inferred from title

docetaxel

1 reference

based on heuristic

inferred from title

author

Peter H. Wiernik

series ordinal

6

object named as

P H Wiernik

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

author name string

A I Einzig

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

L M Schuchter

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

A Recio

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

S Coatsworth

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

R Rodriquez

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

publication date

1 June 1996

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

published in

Medical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

volume

13

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

page(s)

111-117

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

cites work

Docetaxel (Taxotere) is active in non-small-cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FBF02993861

retrieved

21 January 2018

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FBF02993861

retrieved

21 January 2018

Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma. Analysis of complete and long-term responding patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of docetaxel (Taxotere), a highly active new agent for the treatment of metastatic breast cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential applications of the interferons in oncology: lessons drawn from studies of human melanoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of malignant melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical drug development: an analysis of phase II trials, 1970-1985

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DTIC (NSC-45388) in malignant melanoma: a perspective

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of taxol in metastatic melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel (Taxotere) in advanced renal cell cancer. A phase II trial of the EORTC early clinical trials group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma. IV. Late results after complete response to chemotherapy (Central Oncology Group protocols 7130, 7131, and 7131A)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of taxol in patients with malignant melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival and prognostic factors of patients with skin melanoma. A regression-model analysis based on nationwide cancer registry data

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results with methyl-CCNU and DTIC in metastatic melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of Taxotere: five-day schedule

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/9013474

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF02993861

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

Dimensions Publication ID

1026370951

0 references

Fatcat ID

release_zhaskitmoberphnueowlehjgvu

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/zhaskitmoberphnueowlehjgvu

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

9013474

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9013474

retrieved

22 September 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40667276&oldid=2203876189"